findmyKOL
Clinical trialNCT03513328CompletedPhase 1/PHASE2Interventional

Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation

SponsorUniversity of FloridaEnrollment6Acquired Anemia HemolyticAcquired Neutropenia in NewbornAcquired ThrombocytopeniaAdrenoleukodystrophyBone Marrow Failure SyndromeChronic Granulomatous Disease+10 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

In this study, the investigators test 2 dose levels of thiotepa (5 mg/kg and 10 mg/kg) added to the backbone of targeted reduced dose IV busulfan, fludarabine and rabbit anti-thymocyte globulin (rATG) to determine the minimum effective dose required for reliable engraftment for subjects undergoing hematopoietic stem cell transplantation for non-malignant disease.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Uf Health Shands Children'S Hospital

    Gainesville, Florida, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Thiotepa--escalated doseThiotepa--single daily dose
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Jun 2018
Primary completion
17 Feb 2022
Completion
19 Feb 2023
Last update posted
15 Sept 2023
Registered enrollment
6
Registry id
NCT03513328
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.